Mann Brenda 4
4 · EYEGATE PHARMACEUTICALS INC · Filed Apr 9, 2021
Insider Transaction Report
Form 4
Mann Brenda
VP of Research & Development
Transactions
- Tax Payment
Common Stock
2021-04-08$4.94/sh−192$948→ 15,884 total
Footnotes (1)
- [F1]Sale of shares to cover taxes due on restricted stock that vested on 04/01/2021.